MYM Nutraceuticals Inc. vs. My Marijuana Inc.
Seite 2 von 39 Neuester Beitrag: 23.07.21 12:44 | ||||
| Eröffnet am: | 01.11.16 10:15 | von: GoldenStock | Anzahl Beiträge: | 967 |
| Neuester Beitrag: | 23.07.21 12:44 | von: JT_Marlin | Leser gesamt: | 401.328 |
| Forum: | Hot-Stocks | Leser heute: | 8 | |
| Bewertet mit: |  | |||
| Seite: < 1 | | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... 39 > | ||||
Ich gehe davon aus, dass es jedzt erst richtig los geht.
Meiner Meinung nach kommt der Zug wieder langsam ins rollen.
Expect the legislation earlier rather than later. Spring window is April-June. McLellan was confident it would be on the early end of this window.
Government wants legalization/adult-use running “no later than 6 months before the next election.”
“Regulation is the hard part, not the legislation.”
Normal track for all this could take 18-24 months.
US does not impact what’s happening in Canada (unless they wants to make problems). There are certainly some concerns with what the feds will do south of the border, but McLellan was quite clear that it should make no impact on our goal of legalizing and restricting access.
Clarity on advertising restrictions. McLellan reiterated the Task Force’s recommendation of plain packaging, but then went on to say that in-store advertising is allowed.
Licensed Producers will be the legal producers in a recreational market.
Provinces want the Federal Government to handle production regulation. But they want to take the reigns around distribution and retail.
.......
TheraCann unterstützt Unternehmen im Cannabis-Markt bei der Erfüllung der gesetzlichen und geschäftlichen Anforderungen. TheraCann gilt als „On-Stop-Lösung“ für den internationalen Cannabis-Markt. Das Beratungsunternehmen ist spezialisiert auf Zulassungsanträge, Planungswesen, Anlagendesign, Anbau, Analysen, Systemintegration sowie Marketing- und Kommunikationsdienste.
Jonathan Fiteni, CEO von MYM sagte: „Wir werden nicht ruhen, bevor unsere Anträge bewilligt sind und alles tun, um unseren Erfolg zu sichern. Das Einbringen eines erfahrenen Teams, das uns in den letzten kritischen Phasen des ACMPR-Verfahrens zur Seite stehen wird, ist Teil unserer Strategie auf dem Weg zu unserem Ziel.
Das Bauprojekt der MYM-Tochter Sublime Culture Inc. steht derzeit kurz vor der Fertigstellung einiger zusätzlicher Konstruktionsänderungen. In Kürze wird die Bewilligung kleinerer Änderungen erwartet, die für einen regelkonformen Betrieb erforderlich sind. Bei jüngsten Unterredungen wurde ein Ausbau der restlichen Flächen im Gebäude erwogen. Auf diese Weise könnten die Techniker von Sublime bereits sieben Monate vor Ablauf der Frist die Baupläne für eine Erweiterung ausarbeiten. Sublime vergrößert seine Anbauflächen für den überdachten Anbau und die Extraktion um weitere 929 m² (10.000 sq.ft.), um die prognostizierte Nachfrage zu decken. Sublime wird voraussichtlich im September 2017 für die Pre-License-Inspektion durch Health Canada bereit sein, um gegen Ende des Jahres die Geschäfte aufnehmen zu können.
diese Woche drüber..... Mal sehen was Kanada heute macht, und die nächsten Tage......!!!
Kurse von 2-3 vielleicht sogar 5 Dollar schaffen kann !! Ich bleibe "LONG" in der Aktie.
Weitere Meinungen ?
2017-04-11 14:31 ET - News Release
Mr. Jonathan Fiteni reports
MYM NUTRACEUTICALS INC. CLOSES ACQUISITION OF LEADING HEMP CBD BRAND "HEMPMED"
MYM Nutraceuticals Inc. has completed its acquisition of 100 per cent of the brand and assets of HempMed, a Toronto-based developer and marketer of hemp-based cannabidiol (CBD) extracts and oil-infused nutraceutical products.
Pursuant to the acquisition agreement between MYM and HempMed, MYM issued 2,500,000 MYM shares to Anthony Lawand, the owner of HempMed, and a further 1,500,000 will be issued to Lawand upon reaching certain monthly and annual sales targets .
The fast growing HempMed brand is expected to do sales in excess of $1,400,000 in the next 12 months. MYM has plans to build a new high-capacity production facility for HempMed that will increase its sales capacity to handle more than $10,000,000 per year. Further, MYM will open new markets and build an effective online retail strategy for the already popular HempMed brand.
MYM has plans to rebrand the entire line of products including upgrading manufacturing facilities for large-scale production capabilities. Online sales and marketing will be a major focus to accelerate worldwide expansion of CBD product sales. With the additional support both financially and professionally the Company believes the CBD product line will be one of its top performers. MYM has retained the senior staff and founder of HempMed on contract for a minimum of 3 years to drive success within the billion-dollar industry.
The CBD nutraceutical market is growing rapidly worldwide due to an explosion of consumer interest and impressive medical studies on the benefits of high quality hemp CBD products. A recent Forbes magazine article estimated that the CBD market will grow to $2.1 billion market by 2020 with $450 million of those sales coming from hemp-based sources. That's a 700% increase from 2016.
"We are pleased to have the HempMed team on board MYM," commented Jonathan Fiteni, CEO of MYM, "We have high expectations for this business division and we will be investing substantial capital in sales and marketing platforms that will engage a wide range of people who are looking for alternative organic plant based products capable of aiding in the relief multiple ailments with little or no side effects."
The current HempMed product line currently consists of over 20 Hemp products and plan to launch several more groundbreaking products over the next 12 months as a direct result of the transaction. MYM plans on expanding HempMed's existing distribution network, which consists of over 60 retail outlets and online sales portals across Canada, the USA, and Internationally. Furthermore, MYM plans to build a brand-new, robust e-commerce website to drive online sales. The current Product line includes signature tinctures, concentrates and oils, edibles, vape products and a line of fast growing pet CBD products, which will join the multi-billion-dollar pet market.
CBD hemp oil and hemp-based nutraceuticals have been some of the strongest components of the cannabis industry. HempMed has developed proprietary technology that allows their CBD products to be not only very effective but of the highest quality and consistency.
MYM is continuing to negotiate acquisitions of complementary businesses and assets in the technology, nutraceuticals and CBD nutraceutical sectors and is currently in talks with other innovative companies.
About MYM
MYM Nutraceuticals Inc. is a public company whose primary focus is developing high-end organic medicinal supplements and topical products. MYM has an interest in the development of high-density farming facilities and other technologies that allow MYM to expand its brand into the global market.
© 2017
Auf geht MYM. Hopp........
mfG
Chinasky
:)
Hat sich ganz schön was getan!
Hab mal noch etwas Geld ausgegeben ;)...
Naja, dass schöne dabei ist, dass diese Gesetzmäßigkeit schon so lange gilt, wie die Börse existiert.
Irgendjemand muss ja unsere Gewinne bezahlen.
In diesem Sinne:"Uns allen weiterhin viel Erfolg!"